GBA1 and neurodegenerative disease: Thus, it is very likely, given the shared genetics, that increasing GCase lysosomal activity in the brain would be a viable therapy to restore lysosomal homeostasis in both neuronopathic GD and GBA1-associated neurodegenerative diseases.